Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression. (Q39668535)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 August 2010

Language	Label	Description	Also known as
English	Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression.	scientific article published on 11 August 2010

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Aqueous extracts of Fructus Ligustri Lucidi enhance the sensitivity of human colorectal carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3 suppression (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

colorectal carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Jin-fang Zhang

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Qi Dong

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Wei-dong Xie

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yang-chao Chen

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Marie C M Lin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ping-chung Leung

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Ya-ou Zhang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Hsiang-fu Kung

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

11 August 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Integrative Cancer Therapies

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

85-91

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20702496%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NF-kappaB mediated activation of bcl-2 in B16F-10 melanoma cells

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Endogenous reverse transcriptase as a mediator of ursolic acid's anti-proliferative and differentiating effects in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Improvement of Ca balance by Fructus Ligustri Lucidi extract in aged female rats.

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Mutations in human TBX3 alter limb, apocrine and genital development in ulnar-mammary syndrome

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

TBX-3, the gene mutated in Ulnar-Mammary Syndrome, is a negative regulator of p19ARF and inhibits senescence

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

The ARF tumor suppressor can promote the progression of some tumors.

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

The T-box repressors TBX2 and TBX3 specifically regulate the tumor suppressor gene p14ARF via a variant T-site in the initiator

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases

1 reference

https://api.crossref.org/works/10.1177%2F1534735410373921

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39668535&oldid=1500944997"